Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Association of CA19-9 and tumor size in treatment monitoring for patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
Authors
Andrew Hahn
A.T. Still University of Health Sciences, Kirksville, MO;
Andrew Hahn , Bethnay Travis , David Hunter , Abbey Colorafi , Christina Regan , Curt Bay , Phillip Koo , Tomislav Dragovich , Michael A. Choti , Madappa N. Kundranda , John Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 693)
DOI
10.1200/JCO.2023.41.4_suppl.693
Abstract #
693
Poster Bd #
J18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The economic impact of short-term imaging with metastatic pancreatic ductal adenocarcinoma.
First Author: Abbey Bayless
Poster
2021 Gastrointestinal Cancers Symposium
The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.
First Author: Hannah Johnson Roberts
Poster
2018 Gastrointestinal Cancers Symposium
Role of C terminal binding proteins (CtBP) in pancreatic adenocarcinoma (PDAC).
First Author: Prashant J. Joshi
Poster
2018 Gastrointestinal Cancers Symposium
Quantitative PET-MRI for early treatment response assessment in pancreatic ductal adenocarcinoma.
First Author: Martin Valera Consunji